MiRNA-20a targets TXNIP to inhibit the activation of NLRP3, ASC and caspase-1 in adjuvant-induced arthritis FLS and to suppress the secretion of IL-1 and MMP-1. The gene discussed is MMP1; the disease is arthritic joint disease.